Quotation on the stock will resume at 18:10ET, according to Nasdaq. Shares had been halted since 06:55ET this morning ahead of the FDA AdCom decision on Omecamtiv Mecarbil.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CYTK:
- Cytokinetics (NASDAQ:CYTK) Stock Falls; Investors Disheartened by Heart Drug Problems
- Cytokinetics Announces Outcome of FDA Advisory Committee Vote On Omecamtiv Mecarbil
- FDA Cardiovascular & Renal Drugs Advisory Committee to hold virtual meeting
- Cytokinetics Stock Trading Halted Today
- Cytokinetics announces Nasdaq halts trading of stock